National Cancer Institute Home at the National Institutes of Health |
Please wait while this form is being loaded....
The Applied Research Program Web site is no longer maintained. ARP's former staff have moved to the new Healthcare Delivery Research Program, the Behavioral Research Program, or the Epidemiology & Genomics Research Program, and the content from this Web site is being moved to one of those sites as appropriate. Please update your links and bookmarks!

Publication Abstract

Authors: von Rosen A, Frisell J, Azavedo E, Auer G

Title: DNA ploidy in screening-detected non-palpable mammary carcinomas.

Journal: Eur J Surg Oncol 16(6):471-4

Date: 1990 Dec

Abstract: Non-palpable breast cancers detected by mammography in women participating in the ongoing screening project at Södersjukhuset, Stockholm, Sweden, were classified by morphological and cytochemical malignancy grading. The women's age ranged between 40 and 64 years, and the clinical course was followed for a minimum of 5 years after primary treatment. No significant difference in disease-free survival was observed in the 66 cases studied (mean age 58 years) where 28% of the tumors were aneuploid and 72% euploid. Our results indicate that prognosis, even for patients with potentially highly malignant tumors, can be altered when their tumors are detected and treated at an early stage.

Last Modified: 03 Sep 2013